GYRE THERAPEUTICS, INC.

GYRE

—

Advanced chart & tools →

GYRE THERAPEUTICS, INC.GYRE

$0.00

+$0.00(+NaN%)Past Year

Jun 25Sep 25Dec 25Mar 26Jun 26

Key statistics

Market cap

—

P/E ratio

—

EPS (diluted)

$0.02

Dividend yield

0.00%

Dividend / share

$0.24

Revenue

$116.59M

Net income

$9.88M

Net margin

8.5%

Gross margin

87.4%

Dividends & financials

GYRE THERAPEUTICS, INC. (GYRE) reported revenue of $116.59M and net income of $9.88M, or $0.02 per diluted share. It pays an annual dividend of $0.24 per share — a yield of 0.00% at the current price. Financial figures are sourced from the company’s latest public filings; the price chart updates live, 24/7, even when the underlying market is closed.